Cargando…
Biodistribution and pharmacokinetics of (188)Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice
BACKGROUND: Nanoliposomes are designed as carriers capable of packaging drugs through passive targeting tumor sites by enhanced permeability and retention (EPR) effects. In the present study the biodistribution, pharmacokinetics, micro single-photon emission computed tomography (micro-SPECT/CT) imag...
Autores principales: | Tsai, Chia-Che, Chang, Chih-Hsien, Chen, Liang-Cheng, Chang, Ya-Jen, Lan, Keng-Li, Wu, Yu-Hsien, Hsu, Chin-Wei, Liu, I-Hsiang, Ho, Chung-Li, Lee, Wan-Chi, Ni, Hsiao-Chiang, Chang, Tsui-Jung, Ting, Gann, Lee, Te-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218575/ https://www.ncbi.nlm.nih.gov/pubmed/22114492 http://dx.doi.org/10.2147/IJN.S23834 |
Ejemplares similares
-
Translating Research for the Radiotheranostics of Nanotargeted (188)Re-Liposome
por: Chang, Chih-Hsien, et al.
Publicado: (2021) -
A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of (188)Re-liposome in patients with metastatic tumors
por: Wang, Shyh-Jen, et al.
Publicado: (2019) -
External beam radiotherapy synergizes (188)Re-liposome against human esophageal cancer xenograft and modulates (188)Re-liposome pharmacokinetics
por: Chang, Chih-Hsien, et al.
Publicado: (2015) -
Correlation between radioactivity and chemotherapeutics of the (111)In-VNB-liposome in pharmacokinetics and biodistribution in rats
por: Lee, Wen-Chuan, et al.
Publicado: (2012) -
(188)Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept
por: Chang, Chia-Ming, et al.
Publicado: (2017)